• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Life Sciences | News, Analysis, Insights - HIT Consultant

Florence Raises $80M to Expand Connectivity Platform for Clinical Trials

by Jasmine Pennic 05/06/2021 Leave a Comment

What You Should Know: - Florence, a site connectivity platform in clinical trials, today announced the close of a $80 million Series C funding round led by Insight Partners, a global venture capital and private equity firm focused on investing in ScaleUp software companies. Existing investors Fulcrum Equity Partners, Bee Partners, and Flashpoint also joined this round. - Based in Atlanta, GA, Florence is a global leader in remote connectivity and electronic document workflow management for
Read More

Cellares Secures $82M to Automate Cell Therapy Manufacturing

by Fred Pennic 05/06/2021 Leave a Comment

Cellares Secures $82M to Automate Cell Therapy Manufacturing


Read More

Cancer Centers: Here’s How We Can Restart Clinical Trials Today

by Marie E. Lamont, President and COO of Inteliquet 05/05/2021 Leave a Comment

Cancer Centers: Here’s How We Can Restart Clinical Trials Today

Biopharmaceutical companies developing cancer treatments need to restart the clinical trials shut down or delayed during the early stages of the coronavirus pandemic. Some are holding back, however, due to a lack of confidence that sufficient eligible patients can be recruited and enrolled in the trials. Recruiting patients into a clinical trial was challenging before COVID-19 hit, and it has only become exponentially more difficult. Sponsors also know many patients have been putting off
Read More

Walgreens Rolls Out Mobile Clinics to Bring COVID-19 Vaccines to Underserved Communities in Chicago

by Jasmine Pennic 05/04/2021 Leave a Comment

Walgreens Rolls Out Mobile Clinics to Bring COVID-19 Vaccines to Underserved Communities in Chicago

What You Should Know: - Walgreens will activate multiple mobile clinics in Chicago. The traveling mobile clinics will focus on bringing COVID-19 vaccines directly to underserved communities and those with barriers to accessing the vaccine. Over the next two months, additional mobile clinics will make stops in a number of locations across the country. - Individuals will be able to walk up to a mobile clinic and receive a vaccination at that time from a Walgreens pharmacy team member.
Read More

DoD, Duke, John Hopkins, HJF, physIQ Launch 18-Month COVID-19 Clinical Trial Study

by Jasmine Pennic 05/04/2021 Leave a Comment

COVID-19 Vaccine Cyber Attacks

What You Should Know: - Today, PhysIQ Inc. announced its partnership with Johns Hopkins University, Duke University and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), to support a clinical trial to evaluate products for early treatment and post-exposure treatment of COVID-19. The 18-month study will assess disease progression and provide early indication of infection. This DOD-funded initiative will assess the role of continuous biosensor
Read More

Phenomix Inks Licensing Deal with Mayo Clinic for Obesity Phenotype Blood Test

by Fred Pennic 05/04/2021 Leave a Comment

Phenomix Inks Licensing Deal with Mayo Clinic for Obesity Phenotype Blood Test

What You Should Know: - Today, Phenomix Sciences announced the company has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes. - The multi-level “omics” MyPhenome™ test leverages technology developed at Mayo Clinic to analyze genomics, metabolomics and hormone levels. Its AI-driven algorithmic solution identifies four specific obesity phenotypes to give doctors the ability to
Read More

CVS Health Launches Employer-Based COVID-19 Vaccination Program

by Fred Pennic 04/29/2021 Leave a Comment

CVS Health Launches Transform Oncology Care Program, Partners with Tempus

What You Should Know: Today, CVS Health announced it recently began administering COVID-19 vaccines at employer-based vaccination clinics through Return Ready, the company’s comprehensive COVID-19 solution that helps employers return and maintain healthy workforces. - With vaccine hesitancy on the rise, federal and state governments are looking to partners, like employers and CVS Health, to help by making vaccines more convenient to access and enhancing public education
Read More

Carevive, COS Ink Partnership to Improve Cancer Care with RWE

by Jasmine Pennic 04/29/2021 Leave a Comment

Carevive, COS Ink Partnership to Improve Cancer Care with RWE

What You Should Know: - Carevive and Clinical Outcome Solutions (COS) announced a new partnership to improve the cancer patient experience using RWE and RWD. The partnership will leverage Carevive’s innovative digital oncology platform to capture the patient experience, and COS’ deep experience in analyzing data, ultimately providing valuable insights for life science companies and regulators alike. - The Carevive platform PROmpt enables cancer care teams to monitor and manage
Read More

Abbott Launches New AI-Powered Coronary Imaging Platform in Europe

by Fred Pennic 04/27/2021 Leave a Comment

Abbott Launches New Coronary AI-Powered Imaging Platform in Europe

What You Should Know: - Abbott announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization. - The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure
Read More

Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices

by Jasmine Pennic 04/21/2021 Leave a Comment

Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices

What You Should Know: - Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patients to participate in clinical research. - SiteBridge Research creates a network of independent, small practice physicians to gather data from a broader, more inclusive patient population and, ultimately, create more widely applicable clinical
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 72
  • Go to page 73
  • Go to page 74
  • Go to page 75
  • Go to page 76
  • Interim pages omitted …
  • Go to page 90
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |